Iktos

Series-A
iktos.ai Biotech & Healthcare
Total Funding $16M
Latest Round $16M Series-A
Last Announced Mar 9, 2023
Investors Undisclosed
Decision Makers 6 Verified

About Iktos

Iktos combines generative AI, retrosynthesis and robotics to accelerate small-molecule drug discovery from design to preclinical candidate, reducing timelines to under 24 months.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website iktos.ai
Domain Registered Date Dec 16, 2017

Social & Network Presence

X / Twitter Profile @IktosAI (1.1K followers) Created on Apr 2018
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $16,000,000 · Series-A

    startupintros.com

  2. Milestone

    X account created (@IktosAI)

    1.1K followers

  3. Milestone

    Website domain registered

    iktos.ai

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Iktos.

Funding History

1 Round
Series-A · Mar 9, 2023

Founders & Leadership

1

Yann Gaston-Mathé

Co-Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts